Transcription
Nima Ziraknejad 0:06
Hello, my name is Nima Ziraknejad. I am the founder and CEO of NZ Technologies.
Pranav Saxena 0:12
My name is Pranav Saxena. I'm the CTO, we develop clutchless interfaces. So working with surgeons since 2013. At in Vancouver, Canada, they came to us with a problem, you know, they're sterile, they can't touch things because they need to remain sterile unless they just scrub out and scrub back in, which is a big problem. So going through a lot of iterative development processes with them, we developed a couple of different touchless technologies, which we'll show you later, but I'm holding one in my hand, which is a pad that doctors can hold while sterile, put in a bag, and then use very unique gestures, simple gestures to work with the images that they have to look at during a procedure. It has evolved from different types of technology foundations that we tested, you know, we use the camera, a fully touchless mode that worked, but only young doctors could use it. And then we went to different places in Canada and the United States carried out a few research studies. And then in the end, at the end of the day, we went back to our roots with capacitive sensing. And so it evolved into this sensor, which is actually under this pad. And you can imagine there's a dome over this pad. And then so I'm able to sense my finger right over the pad, but not from far away. So that's the whole point that the doctor can do their procedure, use the pad continue their procedures.
Nima Ziraknejad 1:30
Obviously by nature, we are a medical device manufacturing company. And during the past 10 years, we have achieved quite a bit in this healthcare industry. However, I'm particularly during the COVID time when the need for touchless interactions. You know, it was a there was a demand for it because we started from the most difficult section which is the surgery room. There is no room for error, there is no room for admission. So you need to build the best of the best for that environment. Right. During COVID. We noticed that oh, there is a big demand in the market for other applications such as, like you go to airports, there are checking kiosks, you go to elevators, they are elevator buttons, these are called high touch surfaces. These are surfaces that are in crowded areas, such as airports, hospitals, buildings, you know, you name it, even when you go to grocery shopping, there are self checkout screens that you do you do your grocery shopping, you have to touch over touch history. So the Harvard toxicology which chronometer show shortly, has had a variety of applications in these fields. And thankfully, in the past three years, we have enabled to commercialize a new product by the name of hover tap, that basically converts existing high tech surfaces screens into a touchless experience. We have been working in this field for almost 10 years now. And we are a Canadian company. And we started the whole thing from Vancouver General Hospital, which is the largest clinical institutions in Western Canada. So this technology has been developed in Canada. And we have a really great system. It's been Canada, United States through our Trade Commissioner Services. So the two countries work together hand in hand to basically bring technologies, you know, across borders. And we have taken advantage of Trade Commissioner Services from Canada, United States, to be introduced to different conferences, trade shows and organizations like LSI that have been really really instrumental in the success of our technology development, further commercialization and more, most importantly, talking to investors in United States. So that has been how you have you have found the LSI and the organization here.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
